Clinical Trial Results:
A randomised open label, six way, cross-over scintigraphic evaluation of the effect of inspiratory flow rate on lung and oropharyngeal deposition with the Respimat(R) inhaler vs a Metered Dose Inhaler (HFA-MDI) using Berodural(R) in patients with Chronic Obstructive Pulmonary Disease (COPD)
Summary
|
|
EudraCT number |
2005-000841-12 |
Trial protocol |
DE |
Global completion date |
07 Dec 2005
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
13 May 2016
|
First version publication date |
06 May 2015
|
Other versions |
|
Summary report(s) |
215.1364 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.